Professor Agnieszka Basta - Kaim, PhD


Professor Agnieszka Basta - Kaim, PhD
Position
Professor

More publications
  • OPUS 22. New approach to the treatment of Alzheimer's disease targeting resolution of inflammation and modulation of biomechanical properties of microglia by FPR2 hybrid agonists. - 2022-05-23 - 2026-05-22
    Grant NCN OPUS 22, 2021/43/B/NZ4/01133
  • CANALETTO 2021. Promoting resolution of inflammation as an innovate therapeutic strategy for central nervous system disorders characterized by neuroinflammation. - 2021-11-30 - 2022-11-29
    Research project between Poland and Italy CANALETTO 2021 PPN/BIT/2021/1/00009 Maj Institute of Pharmacology Polish Academy of Sciences and Università di Bari
  • Grant Joint Programme – Neurodegenerative Disease Research (JPND) - 2019-01-14 - 2023-01-13
    EpiAD: Effect of early and adult-life stress on the brain epigenome: relevance for the occurrence of Alzheimer’s Disease and Diabetes-related dementia. Professor Agnieszka Basta - Kaim, PhD
  • The project of Alzheimer's Association: Drug Development of Pro-resolving ALX/FPR2 Agonists for Alzheimer’s Disease. - 2018-06-04 - 2021-12-31
    Professor Agnieszka Basta-Kaim, PhD (Poland), professor Enza Lacivita, PhD (Italy), professor Lars-Ove Branderburg, PhD (Germany)
  • HARMONIA 9. Modulation of inflammatory processes using new agonists of the formyl peptide receptors ALX/FPR2 as a new therapeutic strategy of depression. - 2018-05-24 - 2022-05-23
    Grant NCN HARMONIA 9 2017/26/M/NZ7/01048; 2018.05.24-2022.05.23
  • OPUS 10. The role of the neuron-microglia CX3CL1-CX3CR1 and CD200-CD200R protein systems in molecular mechanisms of antipsychotic drug actions: in vivo and in vitro study in the neurodevelopmental models of schizophrenia. - 2016-07-20 - 2021-07-19
    Grant NCN OPUS 10 2015/19/B/NZ7/02394; 2016.07.20-2021.07.19
  • OPUS 5. The role of chemokines in the pathogenesis of depression and molecular mechanism of action of antidepressants. - 2014-04-07 - 2017-04-06
    Grant NCN OPUS 5 2013/09/B/NZ7/04096; 2014.04.07-2017.04.06
  • Team Scientific Award of the Division of Medical Sciences of the Polish Academy of Sciences for a series of publications entitled "The importance of dysfunction of selected neuronal and microglial proteins in the prenatal period in the pathomechanisms of schizophrenia – studies in neurodevelopmental models".
    2021-11-25

National

  • Katedra Farmakologii CM UJ (Kraków)
  • Katedra Neurologii CM UJ (Kraków)
  • Zakład Biochemii Toksykologicznej, Wydział Farmaceutyczny CM UJ (Kraków)

International

  • Brain Mind Institute, School of Life Sciences, Ecole Polytechnique Fédérale Lausanne (Lozanna, Szwajcaria)
  • Center for Molecular Neurobiology Hamburg (Hamburg, Niemcy)
  • Centro de Biología Molecular Severo Ochoa, Universidad Autonoma de Madrid (Madryt, Hiszpania)
  • Department of Neurology, University Hospital La Paz (Madryt, Hiszpania)
  • Dipartimento di Farmacia – Scienze del Farmaco, Universita degli Studi di Bari Aldo Moro (Bari, Włochy)
  • Institute for Laboratory Animal Science, University Hospital RWTH (Aachen, Niemcy)